Modifying Duties Addressing the Synthetic Opioid Supply Chain in the People’s Republic of China

Modifying Duties Addressing the Synthetic Opioid Supply Chain in China

Impact Score: 3.8

Timeline: Effective November 10, 2025, at 12:01 a.m. EST

Summary: This executive order reduces the additional ad valorem duty on specific synthetic opioid-related imports from China from 20% to 10%, recognizing China’s commitment to halt problematic chemical exports. The Secretary of Homeland Security, coordinating with multiple agencies, will monitor compliance and may adjust duties if commitments are unmet. Key governmental bodies including DHS, USITC, State, Treasury, and DOJ are involved in enforcement and monitoring, reflecting significant national security, trade, and economic concerns. The order impacts research and policy programs at Vanderbilt University, with potential opportunities for grant funding and academic leadership on public health and international trade.

Key Actions: Vanderbilt should explore grant opportunities related to synthetic opioid trade regulations, analyze geopolitical trade impacts, develop specialized courses on international trade and public health, and monitor legal and funding changes with federal relations.